Invo Fertility, Inc. (IVF) intrinsic value & 10-year financials
Invo Fertility, Inc. (IVF) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 72.4% a year to $6.8M, with an average return on invested capital of 85.2%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.56
- Market cap
- $65.3K
- Revenue (FY2025)
- $6.8M
- Revenue growth (10-yr CAGR)
- 72.4%
- ROIC (10-yr avg)
- 85.2%
- Free cash flow (FY2025)
- -$7.1M
IVF 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $6.8M | -$23.3M | -$214.64 | -$7.1M | -105.8% | -47.9% |
| FY2024 | $6.6M | -$9.1M | -$30.19 | -$3.2M | -123.8% | -58.2% |
| FY2023 | $3.0M | -$8.0M | -$5.13 | -$5.2M | -224.0% | -199.5% |
| FY2022 | $822.2K | -$10.9M | -$0.90 | -$6.6M | -1292.5% | -514.7% |
| FY2021 | $4.2M | -$6.7M | -$0.63 | -$6.4M | -125.4% | 1357.3% |
| FY2020 | $1.0M | -$8.3M | -$0.76 | -$4.8M | -531.7% | 120.3% |
| FY2019 | $1.5M | -$2.2M | -$0.01 | $1.3M | -120.8% | 45.8% |
| FY2018 | $61.0K | -$3.1M | -$0.01 | -$672.4K | -4318.1% | 89.7% |
| FY2017 | $282.1K | -$702.2K | $0.00 | -$181.3K | -227.0% | 13.3% |
| FY2016 | $50.9K | -$2.1M | -$0.01 | -$339.6K | -4146.1% | 45.7% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
INVO Fertility, Inc. is a consistent compounder, expanding top-line revenue at 72.4% annually over the past decade.
INVO Fertility, Inc. has earned high returns on invested capital, averaging 21.5% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Over the decade, INVO Fertility, Inc. shows that management has aggressively returned capital to shareholders by retiring 100.0% of outstanding shares.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, INVO Fertility, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-7129.41 per share.